CSIMarket
Immunomedics Inc   (IMMU)
Other Ticker:  
 
 

Immunomedics Inc 's Yearly Income from Continued Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



IMMU Annual Income from Cont. Operations Growth

2019
2018
2017
2016
2015
Y / Y Annual Income from Cont. Operations Change - - - - -
Annual Income from Cont. Operations (in millions $) $-357.32 $-273.89 $-153.27 $-59.14 $-48.12


Annual Income from Cont. Operations Growth Comment
Immunomedics Inc realized loss from Cont. Operations.

Immunomedics Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2019 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2019 Annual Income from Cont. Operations
Bristol myers Squibb Company -30.06 %$ 3,460.000  millions
Sanofi -35.67 %$ 3,177.440  millions
Stryker Corp -41.37 %$ 2,083.000  millions
Regeneron Pharmaceuticals Inc -13.44 %$ 2,115.800  millions
Fresenius Medical Care Ag -27.61 %$ 1,611.120  millions
Vertex Pharmaceuticals Inc -43.62 %$ 1,176.810  millions
Baxter International Inc -37.98 %$ 1,011.000  millions
Zoetis Inc   5.34 %$ 1,500.000  millions
Koninklijke Philips Nv  6.93 %$ 1,313.760  millions
Intuitive Surgical Inc   22.83 %$ 1,381.800  millions
Laboratory Corporation Of America Holdings -6.67 %$ 824.900  millions
Davita Inc   14.94 %$ 917.145  millions
Universal Health Services Inc   3.72 %$ 827.543  millions
Quest Diagnostics Inc  12.44 %$ 886.000  millions
Illumina Inc   26.60 %$ 990.000  millions
Edwards Lifesciences Corporation  44.96 %$ 1,046.900  millions
Grifols Sa  9.12 %$ 726.481  millions
United Therapeutics Corporation